The BIO, a Korean comprehensive pharmaceutical and biotechnology media specializing in reporting on pharmaceutical and bio issues, R&D, investment, IPOs, etc. (launched in September 2023)
Company Details
- Employees
- 8
- Founded
- -
- Address
- 서울특별시 송파구 송파대로 167 (문정역테라타워) B동 419호, 서울,05855,korea, Republic Of
- Industry
- Internet News
- NAICS
-
Internet Publishing and Broadcasting and Web Search Portals
- Website
- https://www.thebionews.net
- Keywords
- 제약, 바이오, 헬스케어, 의료기기, 신약, 연구개발, 의료, 의약계, R&D, 기술수출, pharmaceutical, new drug, bio, healthcare, medical, newspaper, news, research, korea bio, k-bio.
- HQ
- 서울
The Bio (더바이오) Questions
The Bio (더바이오)'s website is https://www.thebionews.net
The Bio (더바이오)'s LinkedIn profile is https://kr.linkedin.com/company/thebio
The Bio (더바이오) has
8 employees.
View email and phone details for 8
employees at The Bio (더바이오).
The Bio (더바이오)'s industry is
Internet News
The Bio (더바이오)'s top competitors are
Celltrion Inc,
오송첨단의료산업진흥재단,
Sk Bioscience,
히트뉴스,
Korea Biomedical Review,
Bba Insight Pharma,
Biospectator Inc.,
Gc Biopharma (Gc녹십자),
Samsung Biologics,
Lotte Biologics.
The Bio (더바이오)'s categories are Internet News
The Bio (더바이오)'s founding year is 2023
